PAVmed Inc (PAVM) Actualités

Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players

Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players PR...

American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test

American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer...

PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements

PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements PR Newswire NEW YORK, Sept. 16...

Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress

Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International...

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health PR Newswire NEW YORK, Sept...

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of...

Form 8-K - Current report

The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer

The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection...

PAVmed Provides Business Update and Second Quarter 2024 Financial Results

PAVmed Provides Business Update and Second Quarter 2024 Financial Results PR Newswire NEW YORK, Aug. 13, 2024...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results

Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results PR Newswire NEW YORK...

Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event

Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing...

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal...

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Lucid Diagnostics to Participate in Upcoming Investor Conferences PR Newswire NEW YORK, Aug. 5, 2024 NEW YORK...

PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024

PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024 PR Newswire NEW YORK, July 30...